PolyPid (PYPD) announced the appointment of Dr. Nurit Tweezer-Zaks, M.D., M.B.A., as Chief Medical Officer, effective as of August 18, 2025. Dr. Tweezer-Zaks, who has served on PolyPid’s Board of Directors since November 2023, will step down from the Board, effective as of August 17, 2025 as she assumes this new executive role.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PYPD:
- PYPD Upcoming Earnings Report: What to Expect?
- PolyPid files to sell 7.63M ordinary shares for holders
- PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market
- PolyPid Approves Key Resolutions at Annual Shareholder Meeting
- Analysts Predict Up to ~590% Spike for These 2 ‘Strong Buy’ Penny Stocks